By Christine Guo, PhD
Clinical trialists of today stand to gain valuable insights from the hard-earned lessons accumulated over the past decade. Individuals new to this field often concentrate on the aesthetics and functionalities of wearable devices, drawing parallels with their consumer experiences. However, the effective utilization of wearables in clinical trials is deeply rooted in traditional clinical trial practices, emphasizing operations, protocol adherence, and meticulous record retention.
In a previous blog post, we delved into aspects like adoption, endpoint positioning, and regulatory guidance aimed at expediting clinical development through patient-centered digital endpoints. Expanding on this discussion, let's briefly explore three additional factors that significantly influence the success of trials incorporating digital health technology (DHT).